Trademark Search  /  GENE THERAPY READY

GENE THERAPY READY

● Live · Registered

U.S. federal trademark · Serial No. 90673637 · Reg. No. 6927368

Mark
GENE THERAPY READY
Status
Registered
Serial Number
90673637
Registration No.
6927368
Filing Date
April 27, 2021
Registration Date
December 20, 2022
Class(es)
Class 035, Class 042, Class 045

Owners

Advarra, Inc.
03 · Columbia, MD, US
Advarra, Inc.
03 · Columbia, MD, US
Advarra, Inc.
03 · Columbia, MD, US

Goods & Services

Providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, evaluating research sites involved in gene therapy and vaccine research clinical trials to determine whether the organizations conform to an established accreditation standard; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, testing, analysis, and evaluation of gene therapy and vaccine research service providers to determine conformity with established accreditation standards

Providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trials involving human subjects

organizing and administering a network of research sites, namely, business management in the field of clinical trials, specifically, providing governmental registration assistance in the nature of regulatory submission management on behalf of research sites that conduct gene therapy and vaccine research to assist them with clinical research and clinical trials; providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research for business purposes

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "GENE THERAPY READY" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.